In vitro, inhibition of MED8 by transient knockdown led to decreased proliferation and motility in the ccRCC cell lines, potentially serving as a novel therapeutic target in patients suffering from ccRCC. Here, MED8 is linked to nonpapillary renal cell carcinoma.